A laboratory technician at the Synthetic Biology and Biosurveillance Branch at the U.S. Army Medical Research Institute of Infectious Diseases demonstrates the Biodefense Mass Sequencing and Surveillance assay, developed by a team of researchers under the direction of branch chief Lt. Col. Jeffrey Kugelman during the coronavirus pandemic as a way to rapidly test large numbers of Service Members for exposure to COVID-19. BMASS can be used to test for multiple diseases at the same time, extending its potential beyond just COVID-19 surveillance.
| Date Taken: | 10.03.2024 |
| Date Posted: | 10.03.2024 15:07 |
| Photo ID: | 8676535 |
| VIRIN: | 241003-O-SG040-6863 |
| Resolution: | 2048x1366 |
| Size: | 162.36 KB |
| Location: | FORT DETRICK, MARYLAND, US |
| Web Views: | 13 |
| Downloads: | 1 |
This work, MRDC Prepares High-Throughput Infectious Disease Screening Technology for Commercialization [Image 3 of 3], by Paul Lagasse, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
MRDC Prepares High-Throughput Infectious Disease Screening Technology for Commercialization
No keywords found.
